San Francisco, CA, United States of America

Alex M Aronov

This inventor holds 1 USPTO granted patent. Top assignee: University of California. Active years: 2001.


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 105(Granted Patents)


Company Filing History:


Years Active: 2001

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Alex M Aronov: Innovator in Parasitic Infection Treatment

Introduction

Alex M Aronov is a notable inventor based in San Francisco, CA. He has made significant contributions to the field of medicinal chemistry, particularly in the treatment of parasitic infections. His work focuses on developing innovative solutions to combat diseases affecting mammals.

Latest Patents

Aronov holds a patent titled "Substituted 4-phthalimidocarboxanilides as inhibitors of purine salvage phosphoribosyltransferases." This patent discloses the use of certain heterocyclic derivatives for treating parasitic protozoa infections in mammals, specifically targeting bovine trichomoniasis and giardiasis. He has 1 patent to his name, showcasing his commitment to advancing medical science.

Career Highlights

Aronov is affiliated with the University of California, where he continues to engage in research and development. His academic background and professional experience have positioned him as a key figure in his field. His innovative approach to solving complex medical issues has garnered attention and respect from his peers.

Collaborations

Throughout his career, Aronov has collaborated with esteemed colleagues, including Narsimha R Munagala and Irwin D Kuntz. These partnerships have facilitated the exchange of ideas and have contributed to the advancement of research in parasitic infections.

Conclusion

Alex M Aronov is a dedicated inventor whose work has the potential to significantly impact the treatment of parasitic infections in mammals. His innovative research and collaborations highlight his commitment to improving health outcomes through scientific advancements.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…